Last reviewed · How we verify
NCT04332263
Neuromuscular Electrical Stimulation in ICU Patients
NA trial testing Neuromuscular Electrical Stimulation - NMES in Intensive Care Unit Acquired Weakness in 56 participants. Terminated before completion.
1 March 2022
Quick facts
| Lead sponsor | Federal University of Rio Grande do Sul |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 56 |
| Start date | 1 March 2022 |
| Primary completion | 1 March 2022 |
| Estimated completion | 6 June 2024 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- Neuromuscular Electrical Stimulation - NMES
Conditions studied
- Intensive Care Unit Acquired Weakness — all drugs for Intensive Care Unit Acquired Weakness →
Sponsor
Federal University of Rio Grande do Sul
Who can join
18 and older, any sex, with Intensive Care Unit Acquired Weakness. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the present study is to evaluate the effects of neuromuscular electrical stimulation (NMES) combined with conventional physiotherapy (Experimental Group), compared to conventional physiotherapy only (Control Group) in critically ill Intensive Care Unit (ICU) patients, by means of a randomized controlled clinical trial. The investigators expect that the NMES program will be able to reduce muscle structure and function losses compared to control group, and will improve muscle quality faster, will reduce the ventilation time and the total time spent at the ICU, as well as improve functionality of these patients. In addition, the researchers expect to understand which mechanisms determine such adaptations in the musculoskeletal system of these patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04332263
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Intensive Care Unit Acquired Weakness
Currently open trials in the same condition.
- NCT07191743 — Functional Assessment in Critically Ill Patients · recruiting
- NCT06409611 — MUSCLE EFFECTS OF NEUROMUSCULAR ELECTROSTIMULATION IN MECHANICALLY VENTILATED PATIENTS IN AN ICU · NA · recruiting
- NCT06062303 — Hemodynamic Phenotype-Based,Capillary Refill Time-Targeted Resuscitation In Early Septic Shock:ANDROMEDA-SHOCK-2 · NA · recruiting
- NCT04989790 — Clinical Effectiveness of the "PICU Up!" Multifaceted Early Mobility Intervention for Critically Ill Children · NA · recruiting
- NCT05918757 — Efficacy and Safety of Administration of High Levels of Protein to Critically Ill Patients. · NA · active not recruiting
Other Federal University of Rio Grande do Sul trials
Trials by the same sponsor.
- NCT06967493 — Effects of Amazonian Dance on Motor and Non-motor Symptoms of People With Parkinson's: Study Protocol · NA · recruiting
- NCT07470450 — Acute and Chronic Effects of Combined Training on BP in Hypertensives · NA · completed
- NCT07023146 — Effects of Different Power Training Intensities in Older Adults · NA · enrolling by invitation
- NCT06912269 — Effects of Strength Training on the Plantar Flexors' Properties After Achilles Tendon Rupture · NA · recruiting
- NCT06416046 — Efficacy of Photobiomodulation in the Treatment and Relief of Pain in Recurrent Aphthous Stomatitis · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04332263 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Federal University of Rio Grande do Sul
- Last refreshed: 10 June 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04332263.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing